J.B Chemicals & Pharma announces DJSI score of 77

Mumbai: J.B. Chemicals & Pharmaceuticals Limited has announced that latest ESG score has been announced by Dow
Jones Sustainability Index (DJSI), one of the world’s premier indexes in terms of
sustainability.

J. B. Chemicals & Pharmaceuticals Limited’s DJSI score is 77, which will rank presently among the leading pharmaceutical companies in
India and also rank among the leaders in Pharma Globally (Sector: DRG Pharmaceuticals,
DJSI, S&P Global).

“This achievement underscores the Company’s steadfast commitment to
sustainability, corporate responsibility, and environmental, social, and governance (ESG)
excellence,” JB Chemicals stated.

The DJSI ranking is a premier globally recognized benchmark for corporate sustainability,
assessing companies with rigorous evaluation covering Environmental, Social and
Governance and industry specific questionnaires, assessing an average of 23 sustainability
topic through 150 questions/indicators, evaluating around 13,000 companies worldwide
every year.

“JB Pharma’s score reflects its continuous efforts to integrate sustainable practices
into its core business operations.
Over the past year, JB Pharma has implemented several impactful sustainability initiatives,
including renewable energy adoption, rainwater harvesting project, waste reduction
programs, increased governance, community development projects etc. These efforts have
not only contributed to a positive environmental and social footprint but have also
strengthened the Company’s position as a leader in sustainable growth,” it added.

“As JB Pharma continues its journey towards a more sustainable future, it remains committed to upholding the highest standards of corporate governance and responsible business practices, ensuring long-term value creation for all stakeholders,” it further added.

J.B. Pharma was established in 1976. Besides its strong India presence, which accounts for majority of its revenue, its other two
home markets are Russia and South Africa. In India, the company has six brands among the top 300
IPM brands in the country. The company exports its finished formulations to over 40 countries including
the USA. Besides supplying branded generic formulations to several countries, it is also manufactures medicated lozenges. It has eightstate of the art manufacturing facilities in India including
a dedicated manufacturing facility for lozenges. The manufacturing facilities are certified by leading
regulators across the world.
Facebook Comments